Match!
Weihu Wang
Peking University
RadiologyPathologyMitophagyRadiation therapyMedicine
6Publications
2H-index
156Citations
What is this?
Publications 18
Newest
#1Qiuzi ZhongH-Index: 1
#2Liu-Hua Long (PKU: Peking University)
Last. Ting Zhao
view all 16 authors...
Background: To identify multiparametric magnetic resonance imaging (mp-MRI)-based radiomics features as prognostic factors in patients with localized prostate cancer after radiotherapy. Methods: From 2011 to 2016, a total of 91 consecutive patients with T1-4N0M0 prostate cancer were identified and divided into two cohorts for an adaptive boosting (Adaboost) model (training cohort: n=73; test cohort: n=18). All patients were treated with neoadjuvant endocrine therapy followed by radiotherapy. The...
Source
view all 4 authors...
Abstract Objective To evaluate the treatment outcomes and toxicity of volumetric modulated arc therapy (VMAT) in definitive radiotherapy for patients with cervical cancer. Methods Medical records of 440 patients with cervical cancer treated with VMAT in definitive radiotherapy with or without concurrent chemotherapy between January 2010 and June 2015 in our institution were retrospectively reviewed. A dose of 45 Gy was prescribed to the planning target volume with VMAT in 25 fractions, followed ...
Source
#1Weihu Wang (PKU: Peking University)H-Index: 2
Last. Yidi Wang
view all 13 authors...
TPS475Background: In China, esophageal cancer (EC) ranks as the eigth most common cancer and the sixth most common cause of cancer related death. The predominant histological subtype of EC is ESCC....
Source
#1Xiao-Hang Wang (PKU: Peking University)
#2Liu-Hua Long (PKU: Peking University)
Last. Weihu Wang (PKU: Peking University)H-Index: 2
view all 10 authors...
Recurrence is the major cause of mortality in patients with resected HCC. However, without a standard approach to evaluate prognosis, it is difficult to select candidates for additional therapy. A total of 201 patients with HCC who were followed up for at least 5 years after curative hepatectomy were enrolled in this retrospective, multicentre study. A total of 3144 radiomics features were extracted from preoperative MRI. The random forest method was used for radiomics signature building, and fi...
1 CitationsSource
#1Maxiaowei Song (PKU: Peking University)
#2Jianhao Geng (PKU: Peking University)H-Index: 3
Last. Weihu Wang (PKU: Peking University)H-Index: 2
view all 15 authors...
The aim of this study was to explore the impact of including or excluding the ischiorectal fossa (IRF) within the clinical target volume during neoadjuvant chemoradiotherapy (NCRT) using intensity modulated radiotherapy, in locally advanced lower rectal cancer (LALRC). We retrospectively analysed the data of 220 LALRC patients who received NCRT followed by abdominoperineal resection between January 2009 and January 2015. Six patients were excluded because of loss to follow-up, 90 patients receiv...
Source
#1J. You (PKU: Peking University)H-Index: 1
#2Dan Yang (PKU: Peking University)
Last. Anhui Shi (PKU: Peking University)H-Index: 3
view all 9 authors...
【中文题目:同步推量调强放疗在局部晚期非小细胞肺癌中的应用】 【中文摘要:背景与目的 局部晚期非小细胞肺癌(non-small cell lung cancer, NSCLC)的标准治疗方案为放疗联合化疗,但其生存仍不令人满意。随着调强放疗技术的发展,同步推量(simultaneous integrated boost, SIB)技术成为局部晚期NSCLC的研究方向。本研究拟探讨局部晚期NSCLC采用SIB调强放疗技术的有效性和安全性。方法 回顾性分析北京大学肿瘤医院2015年6月-2018年12月采用SIB技术进行放疗的局部晚期NSCLC患者资料,采用Kaplan-Meier方法进行统计分析,分析其疗效、生存及治疗相关毒性。结果 研究纳入93例患者,中位随访时间34.23个月,3年生存率、无进展生存率、无局部区域复发生存率和无远处转移生存率分别为53.0%、37.0%、50.5%和50.5%。3级放射性食管炎发生率为5.4%,≥3级放射性肺炎发生率为2.2%。结论 局部晚期NSCLC采用SIB调强放疗技术安全有效。】 【中文关键词:肺肿瘤;同步推量;有效性】. METHODS: We...
Source
#1Yuting Zhao (Peking Union Medical College)H-Index: 1
Last. Weihu WangH-Index: 2
view all 7 authors...
The safety and efficacy of transcatheter arterial chemoembolization (TACE) plus intensity-modulated radiotherapy (IMRT) combined with sorafenib in hepatocellular carcinoma (HCC) showing macrovascular invasion (MVI) remain controversial. The records of 63 patients with HCC showing MVI, who underwent IMRT plus TACE combined with (28 participants; Group A) or without (35 participants; Group B) sorafenib from 2015 to 2018, were retrospectively reviewed to assess the progression-free survival (PFS), ...
1 CitationsSource
#1Shuai Li (PKU: Peking University)H-Index: 1
#2Dezuo Dong (PKU: Peking University)H-Index: 1
Last. Weihu Wang (PKU: Peking University)H-Index: 2
view all 12 authors...
Purpose: To analyze the prognostic factors and optimal response interval for stereotactic body radiotherapy (SBRT) in patients with lung oligometastases(OM) or oligoprogression(OP) from colorectal cancer (CRC). Method: Patients with lung OM or OP from CRC treated by SBRT at our hospital were included in this retrospective review. The local control (LC), response to SBRT in different evaluation interval and regional metastases (RM) was analyzed. The risk factor for LC and RM was calculated using ...
1 CitationsSource
Source
Source
12